# Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women

> **NCT00163163** · PHASE3 · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 400 (—)

## Conditions studied

- Hypercholesterolaemia

## Interventions

- **PROCEDURE:** Echographic measurements
- **PROCEDURE:** Blood samples

## Key facts

- **NCT ID:** NCT00163163
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 400 (—)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00163163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00163163, "Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00163163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*